Christian Marinaccio, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chorioallantoic Membrane | 5 | 2017 | 47 | 1.340 |
Why?
|
| Microvessels | 5 | 2017 | 544 | 1.250 |
Why?
|
| Tryptases | 3 | 2016 | 190 | 0.960 |
Why?
|
| Primary Myelofibrosis | 5 | 2022 | 215 | 0.770 |
Why?
|
| Neovascularization, Physiologic | 3 | 2015 | 1351 | 0.640 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2021 | 610 | 0.600 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 3 | 2015 | 1377 | 0.570 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2021 | 1097 | 0.550 |
Why?
|
| GATA1 Transcription Factor | 3 | 2022 | 293 | 0.480 |
Why?
|
| Myeloproliferative Disorders | 4 | 2022 | 606 | 0.480 |
Why?
|
| Mast Cells | 4 | 2016 | 1544 | 0.470 |
Why?
|
| Ki-67 Antigen | 1 | 2015 | 644 | 0.450 |
Why?
|
| Neovascularization, Pathologic | 5 | 2017 | 2638 | 0.450 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2023 | 3524 | 0.440 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 294 | 0.440 |
Why?
|
| Pathology | 1 | 2015 | 272 | 0.420 |
Why?
|
| Microscopy | 1 | 2015 | 896 | 0.350 |
Why?
|
| Megakaryocytes | 5 | 2022 | 545 | 0.340 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2015 | 2037 | 0.290 |
Why?
|
| Hodgkin Disease | 1 | 2014 | 1415 | 0.280 |
Why?
|
| Antigens, CD | 1 | 2014 | 4026 | 0.230 |
Why?
|
| Chick Embryo | 5 | 2017 | 983 | 0.210 |
Why?
|
| Software | 1 | 2015 | 4440 | 0.180 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2020 | 131 | 0.180 |
Why?
|
| Heart | 1 | 2013 | 4460 | 0.170 |
Why?
|
| Janus Kinase 2 | 2 | 2019 | 528 | 0.170 |
Why?
|
| F-Box Proteins | 1 | 2020 | 196 | 0.170 |
Why?
|
| STAT5 Transcription Factor | 1 | 2019 | 259 | 0.160 |
Why?
|
| Thrombocythemia, Essential | 1 | 2019 | 105 | 0.160 |
Why?
|
| Calreticulin | 1 | 2018 | 98 | 0.150 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10179 | 0.150 |
Why?
|
| Bone Marrow | 5 | 2022 | 2951 | 0.150 |
Why?
|
| Vidarabine | 1 | 2018 | 345 | 0.150 |
Why?
|
| Liver | 1 | 2013 | 7479 | 0.150 |
Why?
|
| Melanoma | 1 | 2015 | 5508 | 0.140 |
Why?
|
| Phthalazines | 1 | 2018 | 359 | 0.140 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2016 | 90 | 0.130 |
Why?
|
| Thrombopoiesis | 1 | 2017 | 153 | 0.130 |
Why?
|
| Aquatic Organisms | 1 | 2015 | 46 | 0.130 |
Why?
|
| Fractals | 1 | 2015 | 123 | 0.130 |
Why?
|
| Leukemia | 1 | 2023 | 1509 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2014 | 3510 | 0.120 |
Why?
|
| Mastocytosis, Systemic | 1 | 2015 | 100 | 0.120 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2015 | 163 | 0.120 |
Why?
|
| Mutation | 4 | 2023 | 29777 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2018 | 2944 | 0.110 |
Why?
|
| Mitosis | 1 | 2018 | 1207 | 0.110 |
Why?
|
| Endometrium | 1 | 2016 | 423 | 0.110 |
Why?
|
| Animals | 16 | 2023 | 168660 | 0.110 |
Why?
|
| Cytokines | 2 | 2022 | 7324 | 0.110 |
Why?
|
| Chickens | 1 | 2015 | 864 | 0.110 |
Why?
|
| Angiopoietin-1 | 1 | 2013 | 114 | 0.110 |
Why?
|
| Superior Colliculi | 1 | 2013 | 99 | 0.110 |
Why?
|
| Cerebrospinal Fluid | 1 | 2014 | 533 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2015 | 751 | 0.100 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2013 | 599 | 0.090 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2020 | 1352 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2023 | 4552 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 2942 | 0.090 |
Why?
|
| Immunomodulation | 1 | 2014 | 541 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 2850 | 0.090 |
Why?
|
| Cell Separation | 1 | 2016 | 1750 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 2504 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2017 | 3000 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 1861 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2014 | 789 | 0.080 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 851 | 0.080 |
Why?
|
| Translocation, Genetic | 1 | 2014 | 1420 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 5170 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5854 | 0.080 |
Why?
|
| Disease Progression | 2 | 2022 | 13273 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 21824 | 0.080 |
Why?
|
| Apoptosis | 3 | 2018 | 9718 | 0.080 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1596 | 0.070 |
Why?
|
| Endometrial Neoplasms | 1 | 2016 | 1350 | 0.070 |
Why?
|
| Mice | 7 | 2022 | 81154 | 0.070 |
Why?
|
| Biological Products | 1 | 2015 | 859 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 3389 | 0.070 |
Why?
|
| Particulate Matter | 1 | 2017 | 2529 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 11360 | 0.060 |
Why?
|
| Fibrosis | 2 | 2022 | 2030 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2015 | 8939 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3476 | 0.060 |
Why?
|
| Spheroids, Cellular | 2 | 2016 | 348 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 57744 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2015 | 77410 | 0.060 |
Why?
|
| Oxygen | 1 | 2015 | 4189 | 0.060 |
Why?
|
| Air Pollutants | 1 | 2017 | 2816 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2014 | 3583 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18027 | 0.050 |
Why?
|
| Humans | 19 | 2023 | 743811 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2018 | 1434 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 3622 | 0.050 |
Why?
|
| Chromatin | 2 | 2023 | 2931 | 0.050 |
Why?
|
| Aged | 5 | 2019 | 163178 | 0.050 |
Why?
|
| Interleukin-13 | 1 | 2022 | 389 | 0.050 |
Why?
|
| Middle Aged | 6 | 2019 | 213241 | 0.050 |
Why?
|
| Adult | 6 | 2019 | 213889 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 3079 | 0.040 |
Why?
|
| Myocardium | 1 | 2013 | 4775 | 0.040 |
Why?
|
| Female | 10 | 2019 | 380020 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 13691 | 0.040 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 1 | 2019 | 58 | 0.040 |
Why?
|
| Macrophages | 1 | 2014 | 5651 | 0.040 |
Why?
|
| Transcription Factor Brn-3A | 1 | 2018 | 12 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2022 | 1147 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2014 | 3480 | 0.040 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2019 | 105 | 0.040 |
Why?
|
| Polyploidy | 1 | 2018 | 114 | 0.040 |
Why?
|
| Male | 7 | 2019 | 349776 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2019 | 10477 | 0.040 |
Why?
|
| Nitro Compounds | 1 | 2017 | 74 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2019 | 13028 | 0.040 |
Why?
|
| G1 Phase | 1 | 2018 | 415 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 5185 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 9648 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 16674 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 9440 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19894 | 0.040 |
Why?
|
| Dystroglycans | 1 | 2016 | 60 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2016 | 89 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2017 | 403 | 0.030 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2016 | 150 | 0.030 |
Why?
|
| Aquaporin 4 | 1 | 2016 | 153 | 0.030 |
Why?
|
| Dystrophin | 1 | 2016 | 285 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2017 | 360 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 528 | 0.030 |
Why?
|
| Carcinogens | 1 | 2017 | 466 | 0.030 |
Why?
|
| Gene Expression | 2 | 2019 | 7793 | 0.030 |
Why?
|
| Algorithms | 1 | 2015 | 13869 | 0.030 |
Why?
|
| Binding Sites | 1 | 2023 | 6111 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1876 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2018 | 1011 | 0.030 |
Why?
|
| Adult Stem Cells | 1 | 2016 | 216 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 193 | 0.030 |
Why?
|
| Point Mutation | 1 | 2019 | 1623 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 21675 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 1729 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2018 | 2241 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2018 | 1917 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 2749 | 0.030 |
Why?
|
| Metals | 1 | 2017 | 719 | 0.030 |
Why?
|
| Spleen | 1 | 2018 | 2359 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 729 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2017 | 1396 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1799 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2014 | 758 | 0.030 |
Why?
|
| Quinazolines | 1 | 2018 | 1356 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 1855 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2503 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 1081 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2016 | 851 | 0.020 |
Why?
|
| Protein Binding | 1 | 2023 | 9377 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2016 | 1158 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3547 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2018 | 11478 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 1335 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3482 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 5179 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2022 | 23398 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 6311 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 5867 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 5892 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9731 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15993 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5973 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 12786 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12954 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 3320 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2018 | 19232 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 11036 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21733 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7880 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 8430 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 8856 | 0.010 |
Why?
|